You are here

Global Health

Primary tabs

The mission of the Global Health Working Group is to explore and improve current and emerging states of health and human security worldwide.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 
Group description: 
This Working Group is focused on exploring current and emerging states of health and human security worldwide.
Group roles and permissions: 
Use default roles and permissions
Group visibility: 
Public - accessible to all site users

Members

Aboubacar Conte admin Albert Gomez Allan Anthony Carrielaj
Chisina Kapungu ChrisAllen Corey Watts CPetry DeannaPolk Elhadj Drame
Gavin Macgregor... Hadiatou Balde hank_test jranck JSole Kathy Gilbeaux
Lisa Stelly Thomas loguest Maeryn Obley mdmcdonald MDMcDonald_me_com Mika Shimizu
mike kraft njchapman Norea Tiaji Salaam-Blyther tnovotny

Email address for group

Recent studies suggest staying up-to-date on COVID shots helps protect high-risk groups from severe illness

New guidelines suggest certain high-risk groups could benefit from having another dose of a COVID-19 vaccine this spring — and more frequent shots in general — while the broader population could be entering once-a-year territory, much like an annual flu shot.

Medical experts told CBC News that falling behind on the latest shots can come with health risks, particularly for individuals who are older or immunocompromised.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Scientists study evolution of COVID in an effort to head off a resurgence

Rat droppings from New York City. Poop from dog parks in Wisconsin. Human waste from a Missouri hospital. These are some of the materials that are readying us for the next chapter of the coronavirus saga.

More than four years into the pandemic, the virus has loosened its hold on most people’s bodies and minds. But a new variant better able to dodge our immune defenses may yet appear, derailing a hard-won return to normalcy.

Scientists around the country are watching for the first signs.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. FDA approves COVID preventive Pemgarda for immunocompromised persons

 

The Food and Drug Administration (FDA) on March 22 granted emergency use authorization (EUA) for Invivyd's monoclonal antibody to prevent COVID-19 in immunocompromised patients, which fills a gap following the withdrawal of Evusheld in January 2023.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 1.197 seconds.